TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib (Q90602069)
Jump to navigation
Jump to search
scientific article published on 11 March 2020
Language | Label | Description | Also known as |
---|---|---|---|
English | TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib |
scientific article published on 11 March 2020 |
Statements
TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib (English)
Dandan Wu
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference